High glucose and palmitate increases bone morphogenic protein 4 expression in human endothelial cells

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Medicine

Background:

• Diabetic vascular complications are a major health concern.
• Hyperglycemia and elevated free fatty acids are key factors in diabetes.
• Bone morphogenic protein 4 (BMP4) is implicated as a proatherogenic marker.

Purpose of the Study:

• To investigate the effect of hyperglycemia and palmitate (PAL) on BMP4 expression in endothelial cells.
• To determine the role of BMP4 in diabetic vascular complications, including inflammation and oxidative stress.
• To elucidate the signaling pathways involved in BMP4-mediated vascular damage.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs) were treated with high glucose and/or PAL.
• BMP4 expression levels were measured using quantitative methods.
• BMP4 loss-of-function was induced via siRNA transfection.
• Expression of adhesion molecules and reactive oxygen species (ROS) production were assessed.

Main Results:

• High glucose increased BMP4 expression in HUVECs in a dose-dependent manner.
• Palmitate potentiated high glucose-induced BMP4 expression.
• Hyperglycemia and PAL increased adhesion molecules and ROS production.
• BMP4 knockdown negated the effects of high glucose and PAL on adhesion molecules and ROS.
• BMP4 signaling, a proinflammatory marker, was upregulated by hyperglycemia and PAL.

Conclusions:

• BMP4 plays a significant role in the development of atherosclerosis under hyperglycemic conditions and in the presence of free fatty acids.
• BMP4 mediates the induction of inflammatory adhesion molecules and ROS production, contributing to diabetic vascular complications.
• Targeting BMP4 signaling may offer a therapeutic strategy for preventing or treating diabetic vascular disease.